A phase I study of TRS005: An anti-CD20-MMAE antibody-drug conjugate, in relapsed or refractory b cell non-Hodgkin lymphoma

Y-K. Shi,Z-M. Li, Y. Qing, H. Zhang, Y. Jia,H. Jing,Y. Li, X. Tong,H. Liu,L. Li

ANNALS OF ONCOLOGY（2022）

Cited 0|Views25

No score

Key words

lymphoma,trs005,antibody-drug,non-hodgkin

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined